Cinacalcet for Severe Secondary Hyperparathyroidism in Children with End-stage Kidney Disease
Advanced chronic kidney disease with mineral and bone disorder have a significant obstacles to control serum bone profile [serum intact parathyroid hormone (iPTH), calcium and phosphorus] which subsequently have major effect on optimal bone strength, final adult height, and cardiovascular health. A...
Main Authors: | Areej Adel Sheerah, Rafif Ali Al-Ahmed, Sherif M. El-Desoky, Khalid Abdulaziz Alhasan, Amr S. Albanna, Mohamed A. Shalaby, Jameela Abdulaziz Kari |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2021;volume=32;issue=6;spage=1628;epage=1636;aulast=Sheerah |
Similar Items
-
Role of cinacalcet in the treatment of secondary hyperparathyroidism in chronic kidney disease
by: H.K. Aggarwal, et al.
Published: (2013-09-01) -
Acute kidney injury in children with COVID-19: a retrospective study
by: Jameela Abdulaziz Kari, et al.
Published: (2021-05-01) -
Cinacalcet effect on severe hyperparathyroidism
by: Al Saran Khalid, et al.
Published: (2010-01-01) -
Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis.
by: Ariadna Pérez-Ricart, et al.
Published: (2016-01-01) -
THE CARDIOVASCULAR EFFECTS OF CINACALCET IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
by: Sungjin Chung, et al.
Published: (2012-06-01)